“RZ-001,” a Breakthrough Anti-Cancer Drug by Rznomics, Accelerates FDA Fast Track for Brain Cancer Therapy
“RZ-001", an anti-cancer drug developed by Rznomics Inc. (CEO Lee Seong-wook), has been designated by the U.S. Food and Drug ...
“RZ-001", an anti-cancer drug developed by Rznomics Inc. (CEO Lee Seong-wook), has been designated by the U.S. Food and Drug ...
Seegene Inc., on Wednesday, announced that its COVID-19 test kit, Allplex™ 2019-nCoV Assay, received Emergency Use Authorization (EUA) from the ...
Osang Healthcare announced that it received approval from the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) ...
Sugentech said it would begin the mass production of its antibody-based testing kit for COVID-19. The South Korean medical diagnostics ...
Kogene Biotech said that the U.S. Food and Drug Administration (FDA) recently invited South Korea’s COVID-19 detection kit maker to ...
Copyright © 2024 KoreaTechToday | About Us | Terms of Use |Privacy Policy |Cookie Policy| Contact : press@koreatechtoday.com |